MedTrace Logo

Genotypic and Phenotypic Correlates of Resistance to Aspirin

NCT01361620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2013-12-16

Study results available
· View outcomes & findings →

Summary

The study seeks to identify genomic markers associated with aspirin resistance.

Conditions

  • Platelet Dysfunction Due to Aspirin

Interventions

DRUG

aspirin

aspirin 81mg, 7-10 days

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Principal Investigators

  • Jonathan Reiner, MD · GWU Medical Faculty

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361620 on ClinicalTrials.gov